OncoSil obtains FDA humanitarian exemption for bile duct cancer treatment
August 17, 2026
OncoSil’s device is designed for implantation into solid tumours via injection under endoscopic ultrasound guidance.
OncoSil’s device is designed for implantation into solid tumours via injection under endoscopic ultrasound guidance.
Johnson & Johnson MedTech (NYSE: JNJ) today announced the launch of Monarch Quest 3, the latest software iteration for its Monarch robotically assisted bronchoscopy platform.